Related Experiment Video
Updated: May 27, 2026
06:55
Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
Published on: August 4, 2022
Functionalized nanosystems for targeted mitochondrial delivery
Shelley A Durazo1, Uday B Kompella
1Nanomedicine and Drug Delivery Laboratory, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Mitochondrion
|December 6, 2011
Summary
Functionalized nanosystems effectively deliver therapeutic agents to mitochondria, showing promise for treating diseases linked to mitochondrial dysfunction like Alzheimer's and diabetes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Mitochondrial Medicine
Background:
- Mitochondrial dysfunction, characterized by oxidative stress and DNA mutations, is implicated in diseases such as Alzheimer's and diabetes.
- Targeting therapeutic agents to mitochondria is crucial for developing effective treatments for these conditions.
Purpose of the Study:
- To review the application of nanotechnology in developing mitochondria-targeted therapeutic agents.
- To evaluate the efficacy of various functionalized nanosystems for mitochondrial drug delivery.
Main Methods:
- Review of existing literature on functionalized nanosystems for mitochondrial targeting.
- Comparison of polymeric nanoparticles, metallic nanoparticles, and liposomes for drug delivery to mitochondria.
- Assessment of therapeutic activity of nanosystems in treating mitochondrial defects.
Main Results:
- Functionalized nanosystems demonstrate superior efficacy in delivering therapeutic agents to mitochondria compared to non-functionalized systems.
- Polymeric and metallic nanoparticles, along with liposomes, are identified as effective delivery vehicles.
- Studies indicate enhanced therapeutic activity of these targeted systems.
Conclusions:
- Nanotechnology provides powerful tools for developing mitochondria-targeted therapies.
- Functionalized nanosystems represent a promising strategy for treating mitochondrial dysfunction and associated diseases.
- The field of mitochondria-targeted nanotherapeutics is advancing, with significant potential for future applications.
More Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:39Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...